Pricing

OnKure Therapeutics Inc (OKUR)

followers ยท
Sector: HEALTH CARE
Industry: BIOTECHNOLOGY & LIFE SCIENCES
CEO: Nicholas A. Saccomano
Employees:
Web site: onkuretherapeutics.com
6707 WINCHESTER CIRCLE, SUITE 400, BOULDER, CO, 80301
(720) 307-2892
Stock Split History
Date Ratio
2024-10-07 1:10
All 13F Filers Prior Change Hedge Funds 1 Prior Change
We are a clinical-stage biopharmaceutical company focused on discovering and developing precision medicines that target biologically validated drivers of cancers underserved by available therapies. Using a structure- and computational chemistry-driven drug design platform, we are committed to improving clinical outcomes for patients by building a robust pipeline of small-molecule drugs designed to selectively target specific mutations thought to be key drivers of cancer.
Please log in first to see chart
InvestorHistoryShares Held or Principal AmtMarket Value% of PortfolioPrevious % of PortfolioRankChange in Shares% Change in Shares% OwnershipQtr 1st OwnedEst. Avg PriceSourceSource DateDate Reported
No data available